OPTIC, ATROPHY, HEREDITARY, LEBER
Clinical trials for OPTIC, ATROPHY, HEREDITARY, LEBER explained in plain language.
Never miss a new study
Get alerted when new OPTIC, ATROPHY, HEREDITARY, LEBER trials appear
Sign up with your email to follow new studies for OPTIC, ATROPHY, HEREDITARY, LEBER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Single gene therapy injection tested to halt blindness
Disease control CompletedThis study tested whether a single injection of an experimental gene therapy, called GS010, could improve vision in people with a rare inherited eye disease called Leber Hereditary Optic Neuropathy (LHON). The trial involved 39 participants who had recently started losing their v…
Matched conditions: OPTIC, ATROPHY, HEREDITARY, LEBER
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Apr 04, 2026 08:05 UTC
-
Gene therapy injection tested to halt rare form of blindness
Disease control CompletedThis study tested whether a single gene therapy injection (called GS010) could improve vision in people with a rare inherited eye disease called Leber Hereditary Optic Neuropathy (LHON). The trial involved 37 participants who had experienced vision loss for 6 to 12 months. Resear…
Matched conditions: OPTIC, ATROPHY, HEREDITARY, LEBER
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC